FY2027 EPS Estimates for DENTSPLY SIRONA Reduced by Analyst

DENTSPLY SIRONA Inc. (NASDAQ:XRAY) – Analysts at Leerink Partnrs cut their FY2027 earnings per share (EPS) estimates for shares of DENTSPLY SIRONA in a research note issued on Tuesday, October 14th. Leerink Partnrs analyst M. Cherny now expects that the medical instruments supplier will post earnings of $2.31 per share for the year, down from their prior forecast of $2.34. The consensus estimate for DENTSPLY SIRONA’s current full-year earnings is $1.84 per share. Leerink Partnrs also issued estimates for DENTSPLY SIRONA’s FY2028 earnings at $2.63 EPS.

A number of other analysts also recently issued reports on XRAY. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of DENTSPLY SIRONA in a report on Wednesday, October 8th. Evercore ISI reduced their target price on DENTSPLY SIRONA from $17.00 to $13.00 and set an “in-line” rating for the company in a report on Wednesday, October 8th. Barrington Research reduced their target price on DENTSPLY SIRONA from $21.00 to $18.00 and set an “outperform” rating for the company in a report on Friday, August 8th. Stifel Nicolaus reduced their target price on DENTSPLY SIRONA from $19.00 to $17.00 and set a “hold” rating for the company in a report on Friday, August 8th. Finally, UBS Group reduced their target price on DENTSPLY SIRONA from $25.00 to $24.00 and set a “buy” rating for the company in a report on Friday, August 8th. Two analysts have rated the stock with a Buy rating, eleven have assigned a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat.com, DENTSPLY SIRONA presently has a consensus rating of “Hold” and an average target price of $18.00.

DENTSPLY SIRONA Stock Down 1.4%

Shares of NASDAQ XRAY opened at $12.62 on Thursday. The company has a market capitalization of $2.52 billion, a price-to-earnings ratio of -2.66, a price-to-earnings-growth ratio of 0.80 and a beta of 0.96. The company has a debt-to-equity ratio of 1.13, a current ratio of 1.69 and a quick ratio of 1.11. The business has a 50-day moving average of $13.39 and a two-hundred day moving average of $14.53. DENTSPLY SIRONA has a 1 year low of $11.69 and a 1 year high of $24.86.

DENTSPLY SIRONA (NASDAQ:XRAY) last announced its quarterly earnings results on Thursday, August 7th. The medical instruments supplier reported $0.52 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.50 by $0.02. The company had revenue of $936.00 million during the quarter, compared to the consensus estimate of $929.67 million. DENTSPLY SIRONA had a positive return on equity of 16.33% and a negative net margin of 25.85%.DENTSPLY SIRONA’s revenue for the quarter was down 4.9% on a year-over-year basis. During the same period in the previous year, the business earned $0.49 EPS. DENTSPLY SIRONA has set its FY 2025 guidance at 1.800-2.000 EPS.

DENTSPLY SIRONA Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, October 10th. Investors of record on Friday, September 26th were given a $0.16 dividend. This represents a $0.64 annualized dividend and a yield of 5.1%. The ex-dividend date was Friday, September 26th. DENTSPLY SIRONA’s payout ratio is -13.50%.

Hedge Funds Weigh In On DENTSPLY SIRONA

Several institutional investors have recently added to or reduced their stakes in XRAY. Mirae Asset Global Investments Co. Ltd. acquired a new position in DENTSPLY SIRONA in the 1st quarter valued at about $25,000. Brooklyn Investment Group acquired a new position in DENTSPLY SIRONA in the 1st quarter valued at about $26,000. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. acquired a new position in DENTSPLY SIRONA in the 1st quarter valued at about $26,000. Trust Co. of Toledo NA OH acquired a new position in DENTSPLY SIRONA during the 2nd quarter worth approximately $27,000. Finally, Parkside Financial Bank & Trust increased its position in DENTSPLY SIRONA by 620.6% during the 2nd quarter. Parkside Financial Bank & Trust now owns 1,715 shares of the medical instruments supplier’s stock worth $27,000 after purchasing an additional 1,477 shares during the period. Institutional investors and hedge funds own 95.70% of the company’s stock.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.